» Articles » PMID: 37630491

Marine-Derived GMY01 with Anti-Plasmodial and Anticancer Activities: Genome Analysis, In Vitro Bioassay, Metabolite Profiling, and Molecular Docking

Overview
Journal Microorganisms
Specialty Microbiology
Date 2023 Aug 26
PMID 37630491
Authors
Affiliations
Soon will be listed here.
Abstract

To discover novel antimalarial and anticancer compounds, we carried out a genome analysis, bioassay, metabolite profiling, and molecular docking of marine sediment actinobacteria strain GMY01. The whole-genome sequence analysis revealed that sp. GMY01 (7.9 Mbp) is most similar to strain RCPT1-4 with an average nucleotide identity (ANI) and ANI based on BLAST+ (ANIb) values of 98.09 and 97.33% (>95%). An in vitro bioassay of the GMY01 bioactive on FCR3, cervical carcinoma of HeLa cell and lung carcinoma of HTB cells exhibited moderate activity (IC value of 46.06; 27.31 and 33.75 µg/mL) with low toxicity on Vero cells as a normal cell (IC value of 823.3 µg/mL). Metabolite profiling by LC-MS/MS analysis revealed that the active fraction of GMY01 contained carbohydrate-based compounds, C17H29NO14 (471.15880 Da) as a major compound (97.50%) and mannotriose (C18H32O16; 504.16903 Da, 1.96%) as a minor compound. Molecular docking analysis showed that mannotriose has a binding affinity on glutathione reductase (GR) and glutathione-S-transferase (GST) of and on autophagy proteins (mTORC1 and mTORC2) of cancer cells. GMY01 is a potential bacterium producing carbohydrate-based bioactive compounds with anti-plasmodial and anticancer activities and with low toxicity to normal cells.

Citing Articles

Genome mining and metabolite profiling illuminate the taxonomy status and the cytotoxic activity of a mangrove-derived Microbacterium alkaliflavum sp. nov.

Hu W, Deng L, Huang Y, Wang X, Qing J, Zhu H BMC Microbiol. 2025; 25(1):103.

PMID: 40021979 PMC: 11869465. DOI: 10.1186/s12866-025-03801-2.


Characterization of a novel multi-resistant Pseudomonas juntendi strain from China with chromosomal bla and a megaplasmid coharboring bla and bla.

Jiang S, Li Y, Bi K, Yang S, Xia H, Li S BMC Genomics. 2024; 25(1):774.

PMID: 39118048 PMC: 11311922. DOI: 10.1186/s12864-024-10688-2.


Isolation of active compounds from GMY01 and cytotoxic activity on breast cancer cells line.

Febriansah R, Hertiani T, Widada J, Taher M, Damayanti E, Mustofa M Heliyon. 2024; 10(2):e24195.

PMID: 38293453 PMC: 10826645. DOI: 10.1016/j.heliyon.2024.e24195.

References
1.
Overbeek R, Olson R, Pusch G, Olsen G, Davis J, Disz T . The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST). Nucleic Acids Res. 2013; 42(Database issue):D206-14. PMC: 3965101. DOI: 10.1093/nar/gkt1226. View

2.
Ale M, Mikkelsen J, Meyer A . Important determinants for fucoidan bioactivity: a critical review of structure-function relations and extraction methods for fucose-containing sulfated polysaccharides from brown seaweeds. Mar Drugs. 2011; 9(10):2106-2130. PMC: 3210621. DOI: 10.3390/md9102106. View

3.
Xu X, Chen L, Chen C, Tang Y, Bai F, Su C . Genome Mining of the Marine Actinomycete sp. DUT11 and Discovery of Tunicamycins as Anti-complement Agents. Front Microbiol. 2018; 9:1318. PMC: 6019454. DOI: 10.3389/fmicb.2018.01318. View

4.
Chaube U, Rawal R, Jha A, Variya B, Bhatt H . Design and development of Tetrahydro-Quinoline derivatives as dual mTOR-C1/C2 inhibitors for the treatment of lung cancer. Bioorg Chem. 2020; 106:104501. DOI: 10.1016/j.bioorg.2020.104501. View

5.
Paulus C, Rebets Y, Tokovenko B, Nadmid S, Terekhova L, Myronovskyi M . New natural products identified by combined genomics-metabolomics profiling of marine Streptomyces sp. MP131-18. Sci Rep. 2017; 7:42382. PMC: 5301196. DOI: 10.1038/srep42382. View